Calidi Biotherapeutics (CLDI) Short Interest Ratio & Short Volume

Short interest is the volume of Calidi Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 295,100 shares of CLDI short. Learn More on Calidi Biotherapeutics' current short interest.

Calidi Biotherapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 295,100 shares, an increase of 547.1% from the previous total of 45,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Calidi Biotherapeutics: Aligos Therapeutics, Inc. (1.41%), IN8bio, Inc. (0.36%), Cyclo Therapeutics, Inc. (0.17%), OKYO Pharma Limited (0.34%), Brainstorm Cell Therapeutics Inc. (2.01%), Achilles Therapeutics plc (0.04%), Quince Therapeutics, Inc. (6.17%), Estrella Immunopharma, Inc. (0.10%), Surrozen, Inc. (1.66%), MiNK Therapeutics, Inc. (5.18%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

Short selling CLDI is an investing strategy that aims to generate trading profit from Calidi Biotherapeutics as its price is falling. CLDI shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Calidi Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLDI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLDI, twice per month. The most recent reporting period available is May, 15 2024.